|
Volumn 57, Issue 5-6, 2001, Pages 433-440
|
Blood donors on medication: Are deferral periods necessary?
|
Author keywords
Blood donors; Blood products; Drug safety
|
Indexed keywords
ACEBUTOLOL;
ACETYLSALICYLIC ACID;
ALENDRONIC ACID;
ALLOPURINOL;
AMILORIDE;
AMIODARONE;
AMITRIPTYLINE;
AMLODIPINE;
ANTACID AGENT;
ANTIBIOTIC AGENT;
ANTIFUNGAL AGENT;
ANTIHISTAMINIC AGENT;
ANTIVIRUS AGENT;
ASTEMIZOLE;
ATENOLOL;
ATORVASTATIN;
ATROPINE;
AZAPROPAZONE;
BENZBROMARONE;
BISOPROLOL;
BROMOCRIPTINE;
BUMETANIDE;
CALCITONIN;
CANDESARTAN;
CAPTOPRIL;
CARBIMAZOLE;
CARVEDILOL;
CHEMICAL TERATOGEN;
ETRETIN;
UNINDEXED DRUG;
AMINOSALICYLIC ACID;
BEZAFIBRATE;
BUPRENORPHINE;
DRUG METABOLITE;
TERATOGENIC AGENT;
ARTICLE;
BLOOD COMPONENT;
BLOOD DONOR;
BLOOD GROUP TYPING;
CALCULATION;
DRUG BLOOD LEVEL;
DRUG ELIMINATION;
DRUG FORMULATION;
DRUG HALF LIFE;
DRUG SAFETY;
HEMODILUTION;
HUMAN;
PLASMA VOLUME;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
RECIPIENT;
RISK FACTOR;
BLOOD TRANSFUSION;
CONTROLLED STUDY;
DILUTION;
DRUG CONCENTRATION;
DRUG USE;
RISK;
SAFETY;
ABNORMALITIES, DRUG-INDUCED;
BLOOD COMPONENT TRANSFUSION;
BLOOD DONORS;
CHILD;
DRUG THERAPY;
HALF-LIFE;
HUMANS;
INFANT, NEWBORN;
PHARMACEUTICAL PREPARATIONS;
PHARMACOKINETICS;
TERATOGENS;
TIME FACTORS;
|
EID: 0035738557
PISSN: 00316970
EISSN: None
Source Type: Journal
DOI: 10.1007/s002280100328 Document Type: Article |
Times cited : (13)
|
References (23)
|